Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer

Abstract To evaluate the role of chemotherapy in stage IA triple-negative breast cancer, we conducted a retrospective population-based study including 8601 patients. The use of chemotherapy significantly increased from 2010 to 2019 in patients with T1b and T1c tumors (p = 0.001 and p < 0.001, res...

Full description

Bibliographic Details
Main Authors: Paolo Tarantino, Julieta Leone, Carlos T. Vallejo, Rachel A. Freedman, Adrienne G. Waks, Olga Martínez-Sáez, Ana Garrido-Castro, Filipa Lynce, Nabihah Tayob, Nancy U. Lin, Sara M. Tolaney, Jose P. Leone
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-024-00634-6

Internet

https://doi.org/10.1038/s41523-024-00634-6

Similar Items